Ignite Creation Date:
2024-05-06 @ 8:17 AM
Last Modification Date:
2024-10-26 @ 11:58 AM
Study NCT ID:
NCT02703272
Status:
TERMINATED
Last Update Posted:
2022-12-02
First Post:
2016-03-03
Brief Title:
A Safety and Efficacy Study of Ibrutinib in Pediatric and Young Adult Participants With Relapsed or Refractory Mature B-cell Non-Hodgkin Lymphoma
Sponsor:
Janssen Research Development LLC
Organization:
Janssen Research Development LLC
Organization Data
Organization:
Janssen Research Development LLC
Class:
INDUSTRY
Study ID:
CR108134
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Janssen Research Development LLC
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| Pharmacyclics LLC | INDUSTRY |